JOHN STRUNK: Open Payments
NPI 1811983596 · DOTHAN, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,123 in 254 payments from 18 companies in 2025. Trend: 2023 $9,134 · 2024 $3,997 · 2025 $4,123
Food & beverage: $4,119Education: $4
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 30 | $693 |
| Otsuka America Pharmaceutical, Inc. | 31 | $592 |
| Tris Pharma Inc | 39 | $494 |
| Neurocrine BioSciences, Inc. | 26 | $489 |
| Axsome Therapeutics, Inc. | 19 | $365 |
| Alkermes, Inc. | 17 | $286 |
| Corium, LLC | 24 | $264 |
| ABBVIE INC. | 24 | $239 |
| Teva Pharmaceuticals USA, Inc. | 17 | $210 |
| Almatica Pharma LLC | 11 | $199 |
Products named: FANAPT, REXULTI, Dyanavel XR, INGREZZA, Auvelity, ARISTADA, Azstarys, VRAYLAR.
Industry payments across AL — which companies pay providers there.
